masterThesis
Atividade antiofídica do decocto das folhas de jatropha gossypiifolia l. frente o veneno de bothrops jararaca
Fecha
2014-02-25Registro en:
SILVA, Juliana Felix da. Atividade antiofídica do decocto das folhas de jatropha gossypiifolia l. frente o veneno de bothrops jararaca. 2014. 195f. Dissertação (Mestrado Em Ciências Farmacêuticas) - Centro De Ciências Da Saúde, Universidade Federal do Rio Grande do Norte, Natal, 2014.
Autor
Silva, Juliana Felix da
Resumen
Antiophidic activity from decoct of Jatropha gossypiifolia L. leaves against Bothrops
jararaca venom. Snakebites are a serious worldwide public health problem. In Latin
America, about 90 % of accidents are attributed to snakes from Bothrops genus. Currently, the
main available treatment is the antivenom serum therapy, which has some disadvantages such
as inability to neutralize local effects, risk of immunological reactions, high cost and difficult
access in some regions. In this context, the search for alternative therapies to treat snakebites
is relevant. Jatropha gossypiifolia L., a medicinal plant popularly known in Brazil as
“pinhão-roxo”, is very used in folk medicine as antiophidic. So, the aim of this study is to
evaluate the antiophidic properties of this species against enzymatic and biological activities
from Bothrops jararaca snake venom. The aqueous leaf extract of J. gossypiifolia was
prepared by decoction. The inhibition studies were performed in vitro, by pre-incubation of a
fixed amount of venom with different amounts of extract from J. gossypiifolia for 60 min at
37 °C, and in vivo, through oral or intraperitoneal treatment of animals, in different doses, 60
min before venom injection. The proteolytic activity upon azocasein was efficiently inhibited,
indicating inhibitory action upon metalloproteinases (SVMPs) and/or serine proteases
(SVSPs). The extract inhibited the fibrinogenolytic activity, which was also confirmed by
zymography, where it was possible to observe that the extract preferentially inhibits
fibrinogenolytic enzymes of 26 and 28 kDa. The coagulant activity upon fibrinogen and
plasma were significantly inhibited, suggesting an inhibitory action upon thrombin-like
enzymes (SVTLEs), as well as upon clotting factor activators toxins. The extract prolonged
the activated partial thromboplastin time (aPTT), suggesting an inhibitory action toward not
only to SVTLEs, but also against endogenous thrombin. The defibrinogenating activity in
vivo was efficiently inhibited by the extract on oral route, confirming the previous results. The
local hemorrhagic activity was also significantly inhibited by oral route, indicating an
inhibitory action upon SVMPs. The phospholipase activity in vitro was not inhibited.
Nevertheless, the edematogenic and myotoxic activities were efficiently inhibited, by oral and
intraperitoneal route, which may indicate an inhibitory effect of the extract upon Lys49
phospholipase (PLA2) and/ or SVMPs, or also an anti-inflammatory action against
endogenous chemical mediators. Regarding the possible action mechanism, was observed that
the extract did not presented proteolytic activity, however, presented protein precipitating
action. In addition, the extract showed significant antioxidant activity in different models,
which could justify, at least partially, the antiophidic activity presented. The metal chelating
action presented by extract could be correlated with SVMPs inhibition, once these enzymes
are metal-dependent. The phytochemical analysis revealed the presence of sugars, alkaloids,
flavonoids, tannins, terpenes and/or steroids and proteins, from which the flavonoids could be
pointed as major compounds, based on chromatographic profile obtained by thin layer
chromatography (TLC). In conclusion, the results demonstrate that the J. gossypiifolia leaves
decoct present potential antiophidic activity, including action upon snakebite local effects,
suggesting that this species may be used as a new source of bioactive molecules against
bothropic venom.